Calcitonin gene-related peptide (CGRP) inhibits contractions of the prostatic stroma of the rat but not the guinea-pig

Regulatory Peptides

Volumn 91, Issue 1-3, 2000, Pages 63-73

  Ventura, Sabatino ^a   Lau, Winnie A K ^a   Buljubasich, Sretna ^a   Pennefather, Jocelyn N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adrenomedullin; Amylin; CGRP receptors; Human CGRP((8 37)); Prostate; Smooth muscle

Indexed keywords

ADRENOMEDULLIN; AMYLIN; BESTATIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CAPTOPRIL; GLIBENCLAMIDE; N(G) NITROARGININE METHYL ESTER; NORADRENALIN; PHENYLEPHRINE; PHOSPHORAMIDON;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; GUINEA PIG; IMMUNOHISTOCHEMISTRY; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; SMOOTH MUSCLE CONTRACTION;

ADRENOMEDULLIN; AMYLOID; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-ULCER AGENTS; CALCITONIN GENE-RELATED PEPTIDE; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; GLYBURIDE; GLYCOPEPTIDES; GUINEA PIGS; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; LEUCINE; MALE; NG-NITROARGININE METHYL ESTER; NOREPINEPHRINE; PEPTIDES; PROSTATE; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0034725713     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00118-X     Document Type: Article

References (41)

1. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog. Neurobiol. 45:1995;1-98.
2. Dennis T., Fournier A., St. Pierre S., Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J. Pharmacol. Exp. Ther. 251:1989;718-725.
3. Mimeault M., Fournier A., Dumont Y., St. Pierre S., Quirion R. Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J. Pharmacol. Exp. Ther. 258:1991;1084-1090.
4. Wisskirchen F.M., Burt R.P., Marshall I. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Br. J. Pharmacol. 123:1998;1673-1683.
5. Lamano Carvalho T.L., Hodson N.P., Blank M.A., Watson P.F., Mulderry P.K., Bishop A.E., Gu J., Bloom S.R., Polak J.M. Occurrence, distribution and origin of peptide-containing nerves of guinea-pig and rat male genitalia and the effects of denervation on sperm characteristics. J. Anat. 149:1986;121-141.
6. Chow P.H., Dockery P., Cheung A. Innervation of accessory sex glands in the adult male golden hamster and quantitative changes of nerve densities with age. Andrologia. 29:1997;331-342.
7. Danuser H., Springer J.P., Katofiasc M.A., Thor K.B. Extrinsic innervation of the cat prostate gland: a combined tracing and immunohistochemical study. J. Urol. 157:1997;1018-1024.
8. Chapple C.R., Crowe R., Gilpin S.A., Gosling J., Burnstock G. The innervation of the human prostate gland - the changes associated with benign enlargement. J. Urol. 146:1991;1637-1644.
9. Jen P.Y.P., Dixon J.S. Development of peptide-containing nerves in the human fetal prostate gland. J. Anat. 187:1995;169-179.
10. Tainio H. Peptidergic innervation of the human prostate, seminal vesicle and vas deferens. Acta Histochem. 97:1995;113-119.
11. Jen P.Y.P., Dixon J.S., Gosling J.A. Co-localisation of tyrosine hydroxylase, nitric oxide synthase and neuropeptides in neurons of the human postnatal male pelvic ganglia. J. Auton. Nerv. Syst. 59:1996;41-50.
12. Hedlund P., Ekström P., Larsson B., Alm P., Andersson K.-E. Heme oxygenase and NO-synthase in the human prostate - relation to adrenergic, cholinergic and peptide-containing nerves. J. Auton. Nerv. Syst. 63:1997;115-126.
13. Gkonos P.J., Lokeshwar B.L., Balkan W., Roos B.A. Neuroendocrine peptides stimulate adenyl cyclase in normal and malignant prostate cells. Reg. Pept. 59:1995;43-51.
14. Watts S.W., Cohen M.L. Effect of bombesin, bradykinin, substance P and CGRP in prostate, bladder body and neck. Peptides. 12:1991;1057-1062.
15. Takenaga M., Kawasaki H. Endogenous calcitonin gene-related peptide suppresses vasoconstriction mediated by adrenergic nerves in rat mesenteric resistance blood vessels. Eur. J. Pharmacol. 367:1999;239-245.
16. Kirby R.S. Alpha-adrenoceptor inhibitors in the treatment of benign prostatic hyperplasia. Am. J. Med. 87:1989;26S-30S.
17. Eri L.M., Tveter K.J. Alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia. J. Urol. 154:1995;923-934.
18. Hieble J.P., Ruffolo R.R. Jr. The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: an overview. Pharmacol. Res. 33:1996;145-160.
19. Lau W.A.K., Ventura S., Pennefather J.N. Pharmacology of neurotransmission to the smooth muscle of the rat and the guinea-pig prostate glands. J. Auton. Pharmacol. 18:1998;349-356.
20. Lau W.A.K., Ventura S., Jiang Q., Pennefather J.N. Endothelin-induced facilitation of sympathetic neurotransmission to the rat vas deferens: effects of suramin. Eur. J. Pharmacol. 272:1995;31-38.
21. Fisher L., Pennefather J.N. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors. Eur. J. Pharmacol. 335:1997;221-226.
22. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
23. Ludbrook J. Repeated measures and multiple comparisons in cardiovascular research. Cardiovasc. Res. 28:1994;303-311.
24. Ventura S., Bavetta S., Milner P., Ralevic V., Burnstock G. Nitric oxide synthase is co-localized with vasoactive intestinal polypeptide in postganglionic parasympathetic nerves innervating the rat vas deferens. Neusoscience. 83:1998;607-616.
25. Filippelli A., Falciani M., Piucci B., D'Amico M., D'Agostino B., Filippelli W., Rossi F. Endothelin-1 affects capsaicin-evoked release of neuropeptides from rat vas deferens. Eur. J. Pharmacol. 364:1999;183-191.
26. Poyner D. Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol. Sci. 16:1995;424-428.
27. Giuliani S., Wimalawansa S.J., Maggi C.A. Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations. Br. J. Pharmacol. 107:1992;510-514.
28. Lei S., Mulvany M.J., Nyborg N.C.B. Characterization of the CGRP receptor and mechanisms of action in rat mesenteric small arteries. Pharmacol. Toxicol. 74:1994;130-135.
29. Sheykhzade M., Nyborg N.C.B. Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats. Br. J. Pharmacol. 123:1998;1464-1470.
30. Longmore J., Hogg J.E., Hutson P.H., Hill R.G. Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification. Eur. J. Pharmacol. 265:1994;53-59.
31. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
32. Foord S.M., Marshall F.H. RAMPs: accessory proteins for seven transmembrane domain receptors. Trends Pharmacol. Sci. 20:1999;184-187.
33. Reslerova M., Loutzenhiser R. Renal microvascular actions of calcitonin gene-related peptide. Am. J. Physiol. 274:(Renal Physiol. 43):1998;F1078-F1085.
34. Stones R.W., Thomas D.C., Beard R.W. Suprasensitivity to calcitonin gene-related peptide but not vasoactive intestinal peptide in women with chronic pelvic pain. Clin. Auton. Res. 2:1992;343-348.
35. + channels in the inhibitory effect of calcitonin gene-related peptide on neurotransmission in rat vas deferens. Eur. J. Pharmacol. 327:1997;209-214.
36. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S.K., Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science. 257:1992;401-403.
37. Najbar-Kaszkiel A.T., Di Iulio J.L., Li C.G., Rand M.J. Characterisation of excitatory and inhibitory transmitter systems in prostate glands of rats, guinea-pigs, rabbits and pigs. Eur. J. Pharmacol. 337:1997;251-258.
38. Takeda M., Tang R., Shapiro E., Burnett A.L., Lepor H. Effects of nitric oxide on human and canine prostates. Adult Urol. 45:1995;440-446.
39. Normandin D.E., Lodge N.J. Pharmacological characterization of the isolated canine prostate. J. Urol. 155:1996;1758-1761.
40. Hedlund P., Ekström P., Larsson B., Alm P., Andersson K.-E. Heme oxygenase and NO-synthase in the human prostate - relation to adrenergic, cholinergic and peptide-containing nerves. J. Auton. Nerv. Syst. 63:1997;115-126.
41. Buljubasich S., Lau W.A.K., Pennefather J.N., Ventura S. An immunohistochemical and pharmacological study of tachykinins in the rat and guinea-pig prostate glands. Eur. J. Pharmacol. 380:1999;137-144.